Cargando…
Exploring the variability of sarcopenia prevalence in a research population using different disease definitions
BACKGROUND: Sarcopenia is the progressive loss of muscle mass and function with age. A number of different sarcopenia definitions have been proposed and utilised in research. This study aimed to investigate how the prevalence of sarcopenia in a research cohort of older adults is influenced by the us...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520157/ https://www.ncbi.nlm.nih.gov/pubmed/37466861 http://dx.doi.org/10.1007/s40520-023-02496-7 |
_version_ | 1785109852467494912 |
---|---|
author | Cegielski, Jessica Bass, Joseph J. Willott, Ruth Gordon, Adam L. Wilkinson, Daniel J. Smith, Ken Atherton, Philip J. Phillips, Bethan E. |
author_facet | Cegielski, Jessica Bass, Joseph J. Willott, Ruth Gordon, Adam L. Wilkinson, Daniel J. Smith, Ken Atherton, Philip J. Phillips, Bethan E. |
author_sort | Cegielski, Jessica |
collection | PubMed |
description | BACKGROUND: Sarcopenia is the progressive loss of muscle mass and function with age. A number of different sarcopenia definitions have been proposed and utilised in research. This study aimed to investigate how the prevalence of sarcopenia in a research cohort of older adults is influenced by the use of independent aspects of these different definitions. METHODS: Data from 255 research participants were compiled. Defining criteria by the European Working Group on Sarcopenia in Older People, the International Working Group on Sarcopenia (IWGS), and the Foundation for the National Institutes of Health were applied. RESULTS: Prevalence of sarcopenia using muscle mass ranged from 4 to 22%. Gait speed and handgrip strength criteria identified 4–34% and 4–16% of participants as sarcopenic, respectively. CONCLUSION: Prevalence of sarcopenia differs substantially depending on the criteria used. Work is required to address the impact of this for sarcopenia research to be usefully translated to inform on clinical practice. |
format | Online Article Text |
id | pubmed-10520157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-105201572023-09-27 Exploring the variability of sarcopenia prevalence in a research population using different disease definitions Cegielski, Jessica Bass, Joseph J. Willott, Ruth Gordon, Adam L. Wilkinson, Daniel J. Smith, Ken Atherton, Philip J. Phillips, Bethan E. Aging Clin Exp Res Short Communication BACKGROUND: Sarcopenia is the progressive loss of muscle mass and function with age. A number of different sarcopenia definitions have been proposed and utilised in research. This study aimed to investigate how the prevalence of sarcopenia in a research cohort of older adults is influenced by the use of independent aspects of these different definitions. METHODS: Data from 255 research participants were compiled. Defining criteria by the European Working Group on Sarcopenia in Older People, the International Working Group on Sarcopenia (IWGS), and the Foundation for the National Institutes of Health were applied. RESULTS: Prevalence of sarcopenia using muscle mass ranged from 4 to 22%. Gait speed and handgrip strength criteria identified 4–34% and 4–16% of participants as sarcopenic, respectively. CONCLUSION: Prevalence of sarcopenia differs substantially depending on the criteria used. Work is required to address the impact of this for sarcopenia research to be usefully translated to inform on clinical practice. Springer International Publishing 2023-07-19 2023 /pmc/articles/PMC10520157/ /pubmed/37466861 http://dx.doi.org/10.1007/s40520-023-02496-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Short Communication Cegielski, Jessica Bass, Joseph J. Willott, Ruth Gordon, Adam L. Wilkinson, Daniel J. Smith, Ken Atherton, Philip J. Phillips, Bethan E. Exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
title | Exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
title_full | Exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
title_fullStr | Exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
title_full_unstemmed | Exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
title_short | Exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
title_sort | exploring the variability of sarcopenia prevalence in a research population using different disease definitions |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520157/ https://www.ncbi.nlm.nih.gov/pubmed/37466861 http://dx.doi.org/10.1007/s40520-023-02496-7 |
work_keys_str_mv | AT cegielskijessica exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT bassjosephj exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT willottruth exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT gordonadaml exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT wilkinsondanielj exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT smithken exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT athertonphilipj exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions AT phillipsbethane exploringthevariabilityofsarcopeniaprevalenceinaresearchpopulationusingdifferentdiseasedefinitions |